Amazon’s Alexa partners with First Databank for virtual drug information

“Alexa, what is Tylenol?”

Amazon’s cloud-based voice service can now answer health questions like this after partnering up with a drug and medical device knowledge company.

For the first time, drug information from First Databank, a provider of drug and medical device knowledge, will be available to consumers using Amazon’s Alexa voice technology. Through an Alexa-enabled device, consumers can access a subset of FDB’s drug information, which has been used by healthcare professionals for more than 40 years. FDB has provided drug databases to be used in a variety of applications in the healthcare industry, including other consumer-facing apps.

The information is specifically tailored to Alexa by FDB clinicians, and can help consumers answer questions such as what type of drug is ibuprofen; what are the side effects of sertraline; does Zoloft interact with Aleve; and more. Alexa can answer questions about drug effects, drug interactions, precautions and a drug’s class.

“People lead busy lives and voice provides a simple way to get helpful information about medications including side effects and drug interactions––for themselves and the people they care for––and this information will complement advice from their medical and pharmacy teams,” FDB President Bob Katter said in a statement. “Ultimately, we believe that more informed consumers will lead to improved medication adherence, the reduction of adverse drug events, and better patient outcomes.”

Amazon already has access to free healthcare information from the U.K’s National Health Service under a government contract. And Alexa has the ability to remind patients when to take their medications and request refills for their medicines.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.